RAD (RAD) News
Follow RAD (RAD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Radici Pietro H1 Net Profit €155,000
Radici Pietro Industries & Brands SpA MIL:RAD
NEWS | Sep 28, 2026, 04:27 PM UTC
M
Radiopharm Theranostics reports positive Phase 1 imaging data for RAD301
Radiopharm Theranostics said its Phase 1 imaging trial of RAD301 in pancreatic ductal adenocarcinoma showed positive safety and favourable biodistribution in all dosed subjects, with significant tumour uptake in all eval
EQUITY | Sep 09, 2026, 11:03 AM UTC
M
Lantheus files Schedule 13D showing 20.9% stake in Radiopharm Theranostics
Lantheus Holdings disclosed a 20.9% beneficial stake in Radiopharm Theranostics Limited in a Schedule 13D filed September 4, 2026, with shares and options accumulated across 2024 and 2025.
EQUITY | Sep 04, 2026, 08:48 PM UTC